Header Logo

Connection

Wei Wang to Receptor, Fibroblast Growth Factor, Type 1

This is a "connection" page, showing publications Wei Wang has written about Receptor, Fibroblast Growth Factor, Type 1.
  1. Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. Eur J Med Chem. 2021 Jan 01; 209:112866.
    View in: PubMed
    Score: 0.179
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.